Apple’s AI Entrance & What EU Politics Mean for the US 6/11/24
Apple has entered the AI arms race. WSJ personal tech columnist Joanna Stern discusses the OpenAI-Siri integration, Genmoji, privacy, and Elon Musk’s reaction to Apple’s announcements at the company’s Worldwide Developers Conference. In the wake of EU elections and a shift to the political right across the bloc, Council on Foreign Relations president emeritus Richard Haass considers implications for US politics. He says it’s a tough time for incumbents, and it’s an uncertain world for whoever wins in the upcoming election. Plus, former media executive Edgar Bronfman is reportedly considering a bid for Paramount’s parent company, CNBC’s Emily Wilkins reports on the bipartisan support to crack down on hotel junk fees, and an FDA advisory panel has endorsed Eli Lilly’s Alzheimer’s drug. Richard Haass - 13:29 Joanna Stern - 22:23 In this episode: Joanna Stern, @JoannaStern Emily Wilkins, @emrwilkins Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Apple has entered the AI arms race. WSJ personal tech columnist Joanna Stern discusses the OpenAI-Siri integration, Genmoji, privacy, and Elon Musk’s reaction to Apple’s announcements at the company’s Worldwide Developers Conference. In the wake of EU elections and a shift to the political right across the bloc, Council on Foreign Relations president emeritus Richard Haass considers implications for US politics. He says it’s a tough time for incumbents, and it’s an uncertain world for whoever wins in the upcoming election. Plus, former media executive Edgar Bronfman is reportedly considering a bid for Paramount’s parent company, CNBC’s Emily Wilkins reports on the bipartisan support to crack down on hotel junk fees, and an FDA advisory panel has endorsed Eli Lilly’s Alzheimer’s drug.
Richard Haass - 13:29
Joanna Stern - 22:23
In this episode:
Joanna Stern, @JoannaStern
Emily Wilkins, @emrwilkins
Joe Kernen, @JoeSquawk
Becky Quick,@BeckyQuick
Andrew Ross Sorkin,@andrewrsorkin
Katie Kramer,@Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.